Insider trades
Hans van Houte, CFO of Nurix Therapeutics NRIX, has filed 0 purchases and 32 sales on the open market. Over the past 12 months that comes to a net sale of $452.9K. The latest trade was on 05/05.
Hans van Houte
CFO
- Company
- Nurix Therapeutics NRIX
- First filing
- 23/02/01
- Trades
- 114 trades
- Buys / sales
- 0 / 32
- 12-month net buying
- −$452.9K
- Last trade
- 05/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 05/05 | 05/05 | 14,055 sh2 trades | $16.60avg. | $233,381.1 | −27.2% | |
| Open-market sale | 04/30 | 04/30 | 2,388 sh | $16.65 | $39,760.2 | −4.4% | |
| Open-market sale | 01/30 | 01/30 | 3,661 sh2 trades | $16.60avg. | $60,757.05 | −7.5% | |
| Open-market sale10b5-1 plan | 25/11/03 | 25/11/03 | 6,284 sh | $12.56 | $78,927.04 | −14.3% | |
| Open-market sale | 25/10/30 | 25/10/30 | 3,130 sh | $12.80 | $40,064 | −6.7% | |
| Open-market sale10b5-1 plan | 25/08/01 | 25/08/01 | 5,402 sh | $11.03 | $59,584.06 | −13.2% | |
| Open-market sale | 25/07/30 | 25/07/30 | 4,304 sh | $12.01 | $51,691.04 | −9.5% | |
| Open-market sale10b5-1 plan | 25/05/02 | 25/05/02 | 6,198 sh | $11.33 | $70,223.34 | −15.5% | |
| Open-market sale | 25/04/30 | 25/04/30 | 2,438 sh | $11.50 | $28,037 | −5.8% | |
| Open-market sale10b5-1 plan | 25/03/03 | 25/03/03 | 5,825 sh2 trades | $14.49avg. | $84,391 | −14.7% | |
| Open-market sale | 25/01/30 | 25/01/30 | 2,811 sh2 trades | $19.86avg. | $55,817.99 | −6.6% | |
| Open-market sale10b5-1 plan | 24/11/01 | 24/11/01 | 3,546 sh | $24.28 | $86,096.88 | −9.5% | |
| Open-market sale | 24/10/30 | 24/10/30 | 2,368 sh | $24.31 | $57,566.08 | −6.0% | |
| Open-market sale10b5-1 plan | 24/08/26 | 24/08/26 | 20,000 sh | $25.22 | $504,400 | −39.2% | |
| Open-market sale10b5-1 plan | 24/08/01 | 24/08/01 | 3,477 sh2 trades | $21.45avg. | $74,591.11 | −6.4% | |
| Open-market sale | 24/07/30 | 24/07/30 | 2,490 sh | $20.67 | $51,468.3 | −4.4% | |
| Open-market sale10b5-1 plan | 24/06/20 | 24/06/20 | 20,000 sh | $20.01 | $400,200 | −29.3% | |
| Open-market sale10b5-1 plan | 24/05/02 | 24/05/02 | 3,499 sh | $12.83 | $44,892.17 | −4.9% | |
| Open-market sale | 24/04/30 | 24/04/30 | 1,387 sh | $12.04 | $16,699.48 | −1.9% | |
| Open-market sale10b5-1 plan | 24/02/16 | 24/02/16 | 6,812 sh | $10.02 | $68,256.24 | −9.1% |
